Excellence in research and development of non-coding RNA DIAGnostics in ONcology (RNADIAGON)
- Project Identification
- Project Period
- 2/2019 - 7/2024
- Investor / Pogramme / Project type
- European Union
- MU Faculty or unit
- Central European Institute of Technology
- Cooperating Organization
Universita degli studi di Ferrara
BioVendor - Laboratorní medicína, a.s.
Medical University of Graz
University Hospital Hamburg-Eppendorf
University of Medicine and Pharmacy Iuliu Haţieganu Cluj-Napoca
The University of Texas MD Anderson Cancer Center
Project RNADIAGON aims at development of personal skills and knowledge of early-stage and experienced researchers working in the field of non-coding RNA diagnostics in oncology from 5 European (EU) academic centers (Masaryk University, CEITEC, Czech Republic; University Medical Center Hamburg-Eppendorf, Germany; Iuliu Hatieganu University of Medicine and Pharmacy, Romania; University of Ferrara, Italy; Medical University of Graz, Austria) through their (i) long-term stays at the US research center of excellence (MD Anderson Cancer Center, University of Texas, USA) and (ii) traineeships at the education center and manufacturing facilities of industrial partner (BioVendor, Inc.) developing certified (CE IVD) diagnostics, who will work on the development of a new non-coding RNA diagnostic kit in colorectal cancer adopted here as a model project. This research and innovation staff exchange will increase the scientific excellence and quality of related research in the participating EU research institutions, and enable the dissemination of new technologies and approaches related to this field among other EU research institution as well as interested public.
Sustainable Development Goals
Masaryk University is committed to the UN Sustainable Development Goals, which aim to improve the conditions and quality of life on our planet by 2030.
Total number of publications: 10